RAPP Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $1,079,664.64
Insider Selling (Last 12 Months): $0.00

Rapport Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Rapport Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rapport Therapeutics Share Price & Price History

Current Price: $23.93
Price Change: Price Increase of +0.63 (2.70%)
As of 07/5/2024 01:00 AM ET

This chart shows the closing price history over time for RAPP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Rapport Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/1/2024James HealyDirectorBuy44,032$24.52$1,079,664.6440,851View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Rapport Therapeutics (NASDAQ:RAPP)

Rapport Therapeutics logo
Rapport Therapeutics Inc. is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc. is based in BOSTON.
Read More on Rapport Therapeutics

Today's Range

Now: $23.93
Low: $22.94
High: $24.70

50 Day Range

MA: N/A

52 Week Range

Now: $23.93
Low: $18.00
High: $27.11

Volume

171,026 shs

Average Volume

324,747 shs

Market Capitalization

$846.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Rapport Therapeutics?

Rapport Therapeutics' top insider shareholders include:
  1. James Healy (Director)
Learn More about top insider investors at Rapport Therapeutics.